The role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) in modern rheumatology
Open Access
- 18 October 2010
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Musculoskeletal Disease
- Vol. 2 (5) , 257-269
Abstract
Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase commonly known as statins are widely used for treating hypercholesterolemia. However, there is much evidence to suggest that statins may have other properties in addition to their cholesterol-lowering effect. In particular, statins may neutralize post-translational prenylation of vitally important regulatory small GTPases, which are involved in several processes such as tissue fibrosis, cell maturation, apoptosis, immune cell maturation, and immune response. The beneficial effect of statins has been reported in animal and in vitro models as well as in some clinical studies. As they have an acceptable safety profile, statins may be considered, in selected cases, as a valuable concomitant therapy in the treatment of rheumatic and autoimmune disorders.Keywords
This publication has 106 references indexed in Scilit:
- Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor‐β signal transductionImmunology, 2010
- Serum Interleukin-6 Correlates With Endothelial Dysfunction in Healthy Men Independently of Insulin SensitivityDiabetes Care, 2007
- Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatinArthritis & Rheumatism, 2006
- Arterial Stiffness Is Related to Systemic Inflammation in Essential HypertensionHypertension, 2005
- Treatment of Relapsing Paralysis in Experimental Encephalomyelitis by Targeting Th1 Cells through AtorvastatinJournal of Experimental Medicine, 2003
- Effects of HMG-CoA Reductase Inhibitors on Coagulation and Fibrinolysis ProcessesDrugs, 2003
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Functional Inhibition of Ras by S - trans , trans -Farnesyl Thiosalicylic Acid Attenuates Atherosclerosis in Apolipoprotein E Knockout MiceCirculation, 2002
- Antiplatelet DrugsDrugs, 1995
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992